A detailed history of J.P. Marvel Investment Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, J.P. Marvel Investment Advisors, LLC holds 46,022 shares of MRNA stock, worth $1.81 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
46,022
Previous 46,112 0.2%
Holding current value
$1.81 Million
Previous $5.48 Million 43.84%
% of portfolio
0.51%
Previous 0.9%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$63.64 - $125.14 $5,727 - $11,262
-90 Reduced 0.2%
46,022 $3.08 Million
Q1 2024

May 08, 2024

BUY
$85.37 - $115.44 $6,402 - $8,658
75 Added 0.16%
46,112 $4.91 Million
Q4 2023

Feb 13, 2024

SELL
$69.51 - $104.43 $5,213 - $7,832
-75 Reduced 0.16%
46,037 $4.58 Million
Q2 2023

Aug 10, 2023

BUY
$118.5 - $160.53 $69,322 - $93,910
585 Added 1.28%
46,112 $5.6 Million
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $142,171 - $206,476
-1,048 Reduced 2.25%
45,527 $6.99 Million
Q3 2022

Oct 24, 2022

BUY
$118.07 - $194.18 $6,729 - $11,068
57 Added 0.12%
46,575 $5.51 Million
Q1 2022

May 12, 2022

SELL
$126.46 - $235.05 $17,072 - $31,731
-135 Reduced 0.29%
46,518 $8.01 Million
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $4.24 Million - $6.92 Million
-18,765 Reduced 28.68%
46,653 $11.8 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $1,553 - $3,391
-7 Reduced 0.01%
65,418 $25.2 Million
Q2 2021

Sep 09, 2021

SELL
$129.91 - $234.98 $41,571 - $75,193
-320 Reduced 0.49%
65,425 $15.4 Million
Q2 2020

Sep 09, 2021

BUY
$29.67 - $80.0 $29,818 - $80,400
1,005 Added 1.55%
65,745 $4.22 Million
Q1 2020

Sep 09, 2021

BUY
$17.78 - $31.58 $669,239 - $1.19 Million
37,640 Added 138.89%
64,740 $1.94 Million
Q1 2019

May 16, 2019

BUY
$14.45 - $23.7 $174,845 - $286,770
12,100 Added 80.67%
27,100 $551,000
Q4 2018

Feb 13, 2019

BUY
$13.52 - $18.8 $202,800 - $282,000
15,000 New
15,000 $229,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track J.P. Marvel Investment Advisors, LLC Portfolio

Follow J.P. Marvel Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.P. Marvel Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on J.P. Marvel Investment Advisors, LLC with notifications on news.